James A. Triccas

This study identifies a novel plasmid-borne ESX type VII secretion system in M. abscessus that enhances intracellular survival in macrophages.

This study develops a chimeric spike antigen vaccine (CoVEXS5) that induces broad immunity against multiple SARS-CoV-2 variants and other sarbecoviruses in animal models.

This study develops an LNP-mRNA vaccine against Mycobacterium tuberculosis that induces strong immune responses and protects mice from infection, with potential for human application.

The paper develops a multiplexed, high-throughput pseudovirus neutralisation assay to measure neutralising antibodies against SARS-CoV-2 variants, showing reliability and consistency across single and multiplexed formats.

This study identifies novel antimicrobial compounds from marine sponges through bioassay-guided fractionation and synthetic validation, showing activity against MRSA and other pathogens.